COSCIENS Biopharma Inc. (CSCI) — Free Cash Flow Generation Index
COSCIENS Biopharma Inc. (CSCI) has a Free Cash Flow Generation Index of 0.65x as of September 2023. Free cash flow of $94.00K represents 1% of operating cash flow ($144.00K). See COSCIENS Biopharma Inc. (CSCI) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
COSCIENS Biopharma Inc. Free Cash Flow Generation Index (2003–2022)
Historical FCF Generation Index trend for COSCIENS Biopharma Inc. across 13 annual periods. Explore COSCIENS Biopharma Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for COSCIENS Biopharma Inc. (2003–2022)
Year-by-year Free Cash Flow Generation Index for COSCIENS Biopharma Inc.. For the full company profile including market capitalisation, see COSCIENS Biopharma Inc. market cap and net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.94x | $4.92 Million | $5.23 Million | $10.57K | ▲ +18.0% |
| 2021 | 0.80x | $2.20 Million | $2.75 Million | $555.99K | ▼ -7.3% |
| 2020 | 0.86x | $3.01 Million | $3.49 Million | $485.46K | ▲ +39.6% |
| 2019 | 0.62x | $416.39K | $675.29K | $3.49 | ▲ +139.7% |
| 2017 | -1.55x | $-1.94 Million | $1.25 Million | $3.20 Million | ▼ -7809.0% |
| 2016 | -0.02x | $-71.44K | $3.63 Million | $3.71 Million | ▲ +65.0% |
| 2015 | -0.06x | $-161.00K | $2.87 Million | $3.03 Million | ▲ +95.2% |
| 2014 | -1.16x | $-2.14 Million | $1.84 Million | $3.98 Million | ▲ +68.5% |
| 2013 | -3.70x | $-1.70 Million | $460.21K | $2.16 Million | ▼ -538.3% |
| 2011 | 0.84x | $668.32K | $791.62K | $123.30K | ▲ +4.2% |
| 2010 | 0.81x | $388.42K | $479.50K | $85.01K | ▲ +54.2% |
| 2006 | 0.53x | $73.86K | $140.59K | $66.73K | ▲ +158.8% |
| 2003 | -0.89x | $-48.63K | $54.42K | $103.05K | — |